(Q42513988)

English

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 November 2017

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study (English)

1 reference

Europe PubMed Central

1 November 2017

phase II clinical trial

0 references

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

object named as

E Alba

1

0 references

author name string

J I Chacon

2

1 reference

Europe PubMed Central

1 November 2017

A Lluch

3

1 reference

Europe PubMed Central

1 November 2017

A Anton

4

1 reference

Europe PubMed Central

1 November 2017

L Estevez

5

1 reference

Europe PubMed Central

1 November 2017

B Cirauqui

6

1 reference

Europe PubMed Central

1 November 2017

E Carrasco

7

1 reference

Europe PubMed Central

1 November 2017

L Calvo

8

1 reference

Europe PubMed Central

1 November 2017

M A Segui

9

1 reference

Europe PubMed Central

1 November 2017

N Ribelles

10

1 reference

Europe PubMed Central

1 November 2017

R Alvarez

11

1 reference

Europe PubMed Central

1 November 2017

A Sanchez-Muñoz

12

1 reference

Europe PubMed Central

1 November 2017

R Sanchez

13

1 reference

Europe PubMed Central

1 November 2017

J A Lopez Garcia-Asenjo

14

1 reference

Europe PubMed Central

1 November 2017

C Rodriguez-Martin

15

1 reference

Europe PubMed Central

1 November 2017

M J Escudero

16

1 reference

Europe PubMed Central

1 November 2017

J Albanell

17

1 reference

Europe PubMed Central

1 November 2017

language of work or name

0 references

publication date

9 October 2012

1 reference

Europe PubMed Central

1 November 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

1 November 2017

136

1 reference

Europe PubMed Central

1 November 2017

2

1 reference

Europe PubMed Central

1 November 2017

487-493

1 reference

Europe PubMed Central

1 November 2017

https://scigraph.springernature.com/pub.10.1007/s10549-012-2100-y

0 references

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

The molecular portraits of breast tumors are conserved across microarray platforms

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Deconstructing the molecular portraits of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Molecular stratification of triple-negative breast cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Iniparib plus chemotherapy in metastatic triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Supervised risk predictor of breast cancer based on intrinsic subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Interactions between BRCA proteins and DNA structure

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2100-Y

21 January 2018

Identifiers

10.1007/S10549-012-2100-Y

1 reference

Europe PubMed Central

1 November 2017

Dimensions Publication ID

0 references

release_uyejqpubrbgw5f2mupkwg2pi2y

1 reference

https://api.fatcat.wiki/v0/release/uyejqpubrbgw5f2mupkwg2pi2y

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42513988&oldid=1960406643"